vs
Healthpeak Properties（DOC）与环联（TRU）财务数据对比。点击上方公司名可切换其他公司
环联的季度营收约是Healthpeak Properties的1.7倍（$1.2B vs $702.9M），Healthpeak Properties净利率更高（51.6% vs 8.6%，领先43.0%），环联同比增速更快（13.0% vs -6.6%），过去两年环联的营收复合增速更高（7.1% vs 0.5%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
环联是美国知名消费者信用报告机构，与益博睿、艾奎法克斯并列美国三大征信机构，总部位于伊利诺伊州芝加哥。目前其业务覆盖30余个国家，累计收集超10亿消费者的信用信息，持有美国几乎所有有信用记录消费者的超2亿份档案，服务超6.5万家企业客户，2014年营收达13亿美元。
DOC vs TRU — 直观对比
营收规模更大
TRU
是对方的1.7倍
$702.9M
营收增速更快
TRU
高出19.6%
-6.6%
净利率更高
DOC
高出43.0%
8.6%
两年增速更快
TRU
近两年复合增速
0.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $1.2B |
| 净利润 | $363.0M | $101.1M |
| 毛利率 | — | — |
| 营业利润率 | 0.7% | 17.4% |
| 净利率 | 51.6% | 8.6% |
| 营收同比 | -6.6% | 13.0% |
| 净利润同比 | 28.3% | 52.5% |
| 每股收益（稀释后） | $0.28 | $0.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCTRU
| Q1 26 | $702.9M | — | ||
| Q4 25 | $719.4M | $1.2B | ||
| Q3 25 | $705.9M | $1.2B | ||
| Q2 25 | $694.3M | $1.1B | ||
| Q1 25 | $702.9M | $1.1B | ||
| Q4 24 | $698.0M | $1.0B | ||
| Q3 24 | $700.4M | $1.1B | ||
| Q2 24 | $695.5M | $1.0B |
净利润DOCTRU
| Q1 26 | $363.0M | — | ||
| Q4 25 | $114.0M | $101.1M | ||
| Q3 25 | $-117.1M | $96.6M | ||
| Q2 25 | $31.7M | $109.6M | ||
| Q1 25 | $42.8M | $148.1M | ||
| Q4 24 | $4.5M | $66.3M | ||
| Q3 24 | $85.9M | $68.0M | ||
| Q2 24 | $146.0M | $85.0M |
毛利率DOCTRU
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — |
营业利润率DOCTRU
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | 17.4% | ||
| Q3 25 | 9.2% | 17.8% | ||
| Q2 25 | 5.7% | 16.9% | ||
| Q1 25 | 7.7% | 23.2% | ||
| Q4 24 | -2.2% | 16.5% | ||
| Q3 24 | 14.1% | 14.4% | ||
| Q2 24 | 22.3% | 17.5% |
净利率DOCTRU
| Q1 26 | 51.6% | — | ||
| Q4 25 | 73.2% | 8.6% | ||
| Q3 25 | -16.6% | 8.3% | ||
| Q2 25 | 4.6% | 9.6% | ||
| Q1 25 | 6.1% | 13.5% | ||
| Q4 24 | 0.7% | 6.4% | ||
| Q3 24 | 12.3% | 6.3% | ||
| Q2 24 | 21.0% | 8.2% |
每股收益（稀释后）DOCTRU
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | $0.52 | ||
| Q3 25 | $-0.17 | $0.49 | ||
| Q2 25 | $0.05 | $0.56 | ||
| Q1 25 | $0.06 | $0.75 | ||
| Q4 24 | $0.02 | $0.33 | ||
| Q3 24 | $0.12 | $0.35 | ||
| Q2 24 | $0.21 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $856.3M |
| 总债务越低越好 | — | $4.9B |
| 股东权益账面价值 | $7.8B | $4.4B |
| 总资产 | $21.6B | $11.1B |
| 负债/权益比越低杠杆越低 | — | 1.11× |
8季度趋势，按日历期对齐
现金及短期投资DOCTRU
| Q1 26 | $-1.2B | — | ||
| Q4 25 | $467.5M | $856.3M | ||
| Q3 25 | $91.0M | $752.5M | ||
| Q2 25 | $89.4M | $690.0M | ||
| Q1 25 | $70.6M | $612.5M | ||
| Q4 24 | $119.8M | $682.0M | ||
| Q3 24 | $180.4M | $646.0M | ||
| Q2 24 | $106.9M | $545.8M |
总债务DOCTRU
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | $4.9B | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | $5.1B | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — |
股东权益DOCTRU
| Q1 26 | $7.8B | — | ||
| Q4 25 | $7.5B | $4.4B | ||
| Q3 25 | $7.6B | $4.5B | ||
| Q2 25 | $7.9B | $4.5B | ||
| Q1 25 | $8.2B | $4.4B | ||
| Q4 24 | $8.4B | $4.2B | ||
| Q3 24 | $8.6B | $4.2B | ||
| Q2 24 | $8.8B | $4.1B |
总资产DOCTRU
| Q1 26 | $21.6B | — | ||
| Q4 25 | $20.3B | $11.1B | ||
| Q3 25 | $19.6B | $11.1B | ||
| Q2 25 | $19.8B | $11.1B | ||
| Q1 25 | $19.8B | $10.9B | ||
| Q4 24 | $19.9B | $11.0B | ||
| Q3 24 | $20.0B | $11.1B | ||
| Q2 24 | $20.2B | $11.0B |
负债/权益比DOCTRU
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | 1.11× | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | 1.20× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $319.5M |
| 自由现金流经营现金流 - 资本支出 | — | $222.8M |
| 自由现金流率自由现金流/营收 | — | 19.0% |
| 资本支出强度资本支出/营收 | 3.4% | 8.3% |
| 现金转化率经营现金流/净利润 | — | 3.16× |
| 过去12个月自由现金流最近4个季度 | — | $661.6M |
8季度趋势，按日历期对齐
经营现金流DOCTRU
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $319.5M | ||
| Q3 25 | $315.0M | $324.3M | ||
| Q2 25 | $363.5M | $291.3M | ||
| Q1 25 | $279.4M | $52.5M | ||
| Q4 24 | $1.1B | $254.0M | ||
| Q3 24 | $318.2M | $229.3M | ||
| Q2 24 | $316.2M | $295.2M |
自由现金流DOCTRU
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | $222.8M | ||
| Q3 25 | — | $240.4M | ||
| Q2 25 | — | $214.3M | ||
| Q1 25 | — | $-15.9M | ||
| Q4 24 | $333.7M | $136.9M | ||
| Q3 24 | — | $161.3M | ||
| Q2 24 | — | $226.9M |
自由现金流率DOCTRU
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | 19.0% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 18.8% | ||
| Q1 25 | — | -1.5% | ||
| Q4 24 | 47.8% | 13.2% | ||
| Q3 24 | — | 14.9% | ||
| Q2 24 | — | 21.8% |
资本支出强度DOCTRU
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | 8.3% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 6.8% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | 105.6% | 11.3% | ||
| Q3 24 | — | 6.3% | ||
| Q2 24 | — | 6.6% |
现金转化率DOCTRU
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | 3.16× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | 11.48× | 2.66× | ||
| Q1 25 | 6.52× | 0.35× | ||
| Q4 24 | 235.43× | 3.83× | ||
| Q3 24 | 3.71× | 3.37× | ||
| Q2 24 | 2.17× | 3.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
TRU
暂无分部数据
